Enjoy complimentary customisation on priority with our Enterprise License!
The Smart Inhaler Technology Market size is estimated to grow by USD 46.37 million at a CAGR of 10.16% between 2022 and 2027. The integration of health technology, digital media, and mobile or smart devices is referred to as connected healthcare. It is also known as technology-enabled care (TEC). The main advantage of this integrated platform it enables patients, caregivers, and healthcare professionals to access the data more easily and modify it remotely. There is a growing popularity for these integrated platforms among patients, clinicians, and healthcare practitioners due to the value-added benefits of TEC. The smart inhalers can be connected to the TEC platform for sharing patients' data. Furthermore, the main advantage of these platforms is that they can be used to share, store, and access patient data such as the level of the chronic condition, medication, test reports, and other patient cases. Hence, such factors are positively impacting the market.
To learn more about this report, Request Free Sample
This report provides a detailed analysis of the market by and Product (Inhalers and Nebulizers), application (asthma and COPD) and Geography (North America, Europe, Asia, and the Rest of the World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2017 to 2021, besides analyzing the current market scenario.
In the market segmentation, the focus is on addressing chronic respiratory diseases (CRDs) through innovative solutions. Connected medical devices, such as the HeroTracker Sense, revolutionize treatment by providing real-time monitoring and data tracking for patients using metered dose inhalers. These devices bridge the gap between hospital and retail pharmacies, enabling seamless access to healthcare services. Telemedicine and remote patient monitoring devices play a crucial role, reducing hospital admissions and patient visits while mitigating respiratory complications. Leveraging digital technology, smart inhalers connect to smartphones and digital devices, particularly beneficial in highly polluted areas where respiratory ailments are prevalent. By integrating smart technology into inhalation therapy, the market aims to enhance patient outcomes and improve respiratory health management.
The inhalers segment is estimated to witness significant growth during the forecast period. One of the primary-stage medication used for various COPD and asthma cases are inhalers. Suitable inhalers are recommended that are available as MDIs or DPIs based on patient conditions. The MDIs are short-acting bronchodilators that use pressurized drugs to treat patients with breathlessness whereas DPIs are long-acting bronchodilators that use a dry, powdered form of drugs, which can be inhaled with full lung capacity to get relief from breathing or pulmonary disorders.
Get a glance at the market contribution of various segments View a PDF Sample
The inhalers segment was the largest segment and was valued at USD 31.22 million in 2017. The main advantage of MDI is that the effect of the drugs is immediate and can last for four to six hours, offering relief against asthma or COPD-related emergencies. On the other hand, DPIs can offer relief for 12 to 24 hours and can be used once or twice per day. There is an increasing preference for inhalers by patients as the first line of treatment due to the rising prevalence of asthma and COPD. There is increasing adoption of smart inhalers among patients as it helps to get consultations from their physicians, and they can remotely access the recorded data of the smart inhalers and prescribe required medications to patients. Hence, such factors are expected to fuel the growth of this segment which in turn will drive the market growth during the forecast period.
There are numerous applications for smart inhalers in treating asthma, as they provide advanced monitoring, data collection, and communication capabilities that can enhance medication adherence, asthma management, and overall patient outcomes. The main feature of smart inhalers is that they monitor medication usage and send reminders to patients when it's time to take their inhalers. As a result, it enables patients to follow their prescribed medication schedule, resulting in better symptom control and reduced risk of asthma exacerbations. Furthermore, it allows the US to monitor and manage the child's medication usage and share data with healthcare providers. Hence, these factors are expected to fuel the growth of this segment which, in turn, will drive the market growth during the forecast period.
There are various applications of smart inhalers in the treatment and management of COPD. COPD can be referred to as a chronic lung condition characterized by airflow limitation and often comprises symptoms including shortness of breath, coughing, and wheezing. The main feature of this technology is that it tracks inhaler usage and offers reminders, ensuring that patients take their prescribed medications as directed. In addition, it helps in generating COPD-specific action plans, enabling patients to manage symptom exacerbations, and offering guidance on when to adjust medications or seek medical attention. Hence, such factors are expected to fuel the growth of this segment which in turn will drive the market growth during the forecast period.
For more insights about the market share of various regions View PDF Sample now!
North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. Some of the main factors that are significantly contributing to the growth of the smart inhaler technology market in North America are the high prevalence of COPD, rising awareness about smart inhalers, and the increasing number of companies.
In addition, factors such as the growing number of R&D facilities for innovative product development and the rising number of advanced product launches are positively impacting the market growth in the region. Furthermore, several prominent market players are increasingly investing in their R&D facilities to develop new products, which is offering a competitive advantage to them and helping to increase their market base. Hence, such factors are driving the market growth in the region during the forecast period.
Smart Inhaler Technology is driven by the urgent need to address chronic respiratory diseases (CRDs) effectively. Connected medical devices like HeroTracker Sense offer real-time monitoring and data analysis, optimizing treatment outcomes. Adoption trends indicate integration with telemedicine and remote patient monitoring devices, reducing hospital admissions and patient visits. However, challenges persist, including accessibility in highly polluted areas and ensuring compatibility with existing healthcare infrastructure. Overcoming these hurdles while leveraging digital technology, such as smart phones and digital devices, is crucial for maximizing the potential of smart inhaler technology in managing respiratory ailments efficiently. There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.
One of the key factors driving the market growth is the rising prevalence of respiratory diseases. There is an increasing prevalence of respiratory diseases which is significantly contributing to the market growth. There is a strong demand for innovative solutions that can improve disease management and enhance patients' quality of life as conditions such as asthma and chronic obstructive pulmonary disease (COPD) affect millions of people worldwide.
Moreover, the increasing number of individuals diagnosed with respiratory diseases has significantly fuelled the potential customer base for smart inhaler technology. There is an increasing adoption of smart inhalers that can provide real-time data and personalized treatment insights as more people require effective management of their conditions. Hence, such factors are positively impacting the market. Therefore, it is expected to drive market growth during the forecast period.
A key factor shaping the market growth is the rising technological advancements. There is a significant development in the capabilities of the and features of smart inhalers due to the advancements in technologies thereby improving the effectiveness in managing respiratory conditions. The incorporation of advanced sensors in smart inhalers enables the detection of inhaler usage and factors including inhalation technique, airflow rate, and medication dispersion within the respiratory tract.
Moreover, there are significant developments in the miniaturization of smart inhalers making it smaller, more portable, and less obtrusive. In addition, these technologies are increasingly equipped with wireless connectivity, allowing seamless data transmission to companion apps, cloud storage, and healthcare provider systems. Hence, such factors are positively impacting the market which in turn will drive the market growth during the forecast period.
Less number of product approvals due to stringent regulations is one of the key challenges hindering the smart inhaler technology market growth. As smart inhalers are considered medical devices under FDA regulation, it is essential to have FDA clearance for commercialization. There are several stringent regulations enforced by the FDA during the clinical trials of smart inhalers which include safety, accuracy, and effectiveness trials of the devices.
Moreover, the market players in the market need to comply with these stringent regulations in order to commercialize the product. As a result, of such stringent regulations, the FDA declines certain approvals at different stages of clinical trials which is negatively impacting the market. Hence, such factors are expected to hinder market growth during the forecast period.
Buy Now Full Report and Discover More
The market research report includes the adoption lifecycle of the market research and growth, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth and forecasting strategies.
Customer Landscape
Buy Now Full Report and Discover More
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
3M Co: The company offers smart inhaler technology, such as the Intelligent Control Inhaler, that provides on-screen instructions.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Million" for the period 2023 to 2027, as well as historical data from 2017 to 2021 for the following segments.
The global smart inhalers market is witnessing rapid growth, fueled by advancements in technology and increasing awareness about respiratory health. Companies like Planet Innovation are at the forefront of innovation, developing smart inhalers that cater to various healthcare settings, including hospital pharmacies, online pharmacies, hospitals, and home care settings. These inhalers come equipped with medication history trackers, clinical data collection features, and Bluetooth connectivity for seamless monitoring. They offer both MDI-based Inhalers and DPI-based inhalers, catering to different patient needs. With the aging population and rising prevalence of respiratory ailments due to factors like tobacco smoke and air pollution, the demand for smart inhalers is on the rise. These devices improve medicinal adherence, dosage accuracy, and treatment outcomes, ultimately reducing hospitalizations and treatment expenses while promoting preventive care.
Additionally, smart inhalers, equipped with medication history tracker & monitoring capabilities, cater to the needs of the aging population base. With the rise of e-commerce and smartphone usage, the adoption of digital technology in healthcare is increasing, facilitating the development of DPI-based smart inhaler and MDI-based smart inhaler. Particularly in regions with high pollen threats and prevalent acute respiratory diseases, these devices offer precise drug dosage and monitoring mechanisms, improving treatment outcomes and reducing hospitalizations. The Lancet Respiratory Medicine highlights the importance of digital device inhalers in enhancing procedural outcomes and promoting dosing adherence. As the market continues to evolve, smart phone integrate with smart inhalers with features like dose remainder and inhalation capacity cater to diverse disease indications, revolutionizing respiratory care.
Market Scope |
|
Report Coverage |
Details |
Page number |
158 |
Base year |
2022 |
Historic period |
2017 - 2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 10.16% |
Market growth 2023-2027 |
USD 46.37 million |
Market structure |
USD Fragmented |
YoY growth 2022-2023(%) |
9.77 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 37% |
Key countries |
US, UK, France, China, and Japan |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
3M Co., Adherium Ltd., Amiko Digital Health Ltd., AptarGroup Inc., AstraZeneca Plc, Cognita Labs, Cohero Health Inc., Findair Sp. z o. o., Infineon Technologies AG, Novartis AG, OPKO Health Inc., ResMed Inc., Sensirion AG, Teva Pharmaceutical Industries Ltd., and Vectura Group plc |
Market dynamics |
Parent market analysis, market forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, Market growth and Forecasting, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the market forecast period |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
View Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.